Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Centessa Pharmaceuticals plc CNTA

Set alert

Price alert · CNTA

All alert types
40.50 USD 0.00 0.00%

At close · Jun 25

40.68 +0.18 +0.45%

After hours · Jun 25, 4:00 PM ET

Bid
40.53 × 1
Ask
40.55 × 1
40.50 Day range 40.50

52-week range unavailable

YTD
+61.94%
1 year
+201.56%
Open
40.50
Prev close
40.50
Mkt cap
6.27B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
40.50
High
40.50
Beta
1.12
Inst. own
96.93%
Dividend
38.00
Earnings
Aug 11, 2026

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Feb 24, 2026Rating: Wolfe Research · — → Outperform
  • Mar 31, 2026Earnings: -0.48; estimate -0.37144; surprise -29.23%
  • Mar 31, 2026Downgrade: Needham · Buy → Hold
  • Mar 31, 2026Downgrade: Wolfe Research · Outperform → Peer Perform
  • Apr 1, 2026Downgrade: Leerink Partners · Outperform → Market Perform
  • Apr 2, 2026Downgrade: Guggenheim · Buy → Neutral
  • Apr 20, 2026Downgrade: Wells Fargo · Overweight → Equal-Weight
  • May 5, 2026Earnings: -0.52; estimate -0.38; surprise -36.84%
  • Jun 24, 2026Dividend: 38
Signals (24)
NameDateAgo
MACD: Buy SignalJun 24, 20264 months ago
RSI: OverboughtJun 22, 20264 months ago
MACD: Sell SignalApr 20, 20266 months ago
MACD: Buy SignalMar 31, 20267 months ago
RSI: OverboughtMar 31, 20267 months ago
MACD: Sell SignalMar 30, 20267 months ago
MACD: Buy SignalMar 26, 20267 months ago
MACD: Sell SignalMar 23, 20267 months ago
SMA: BullishFeb 23, 20268 months ago
SMA: BullishFeb 23, 20268 months ago
SMA: BearishFeb 20, 20268 months ago
SMA: BearishFeb 20, 20268 months ago
SMA: BullishFeb 17, 20268 months ago
SMA: BullishFeb 17, 20268 months ago
MACD: Buy SignalFeb 13, 20268 months ago
MACD: Sell SignalFeb 9, 20268 months ago
SMA: BearishFeb 5, 20269 months ago
SMA: BearishJan 28, 20269 months ago
SMA: BullishJan 27, 20269 months ago
SMA: BullishJan 22, 20269 months ago

Newest 20 of 24.

Analyst view

Price target (mean) —
Ratings (0m) 7 2 buy · 5 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold5
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 13
  • 2 months ago 13
  • 3 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CNTA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.39-0.39 – -0.39-0.38-2.6%00.0%1
Next quarter-0.39-0.39 – -0.39-0.41+4.9%00.0%1
Current year-1.56-1.56 – -1.56-1.46-6.9%0-100.0%1
Next year-1.78-2.06 – -1.30-1.56-14.1%28.57M0.0%5

Upgrades and downgrades

The latest rating changes

CNTA analyst upgrades and downgrades
DateFirmActionFromTo
Apr 20, 2026Wells FargoDowngradeOverweightEqual-Weight
Apr 2, 2026GuggenheimDowngradeBuyNeutral
Apr 1, 2026Leerink PartnersDowngradeOutperformMarket Perform
Mar 31, 2026Wolfe ResearchDowngradeOutperformPeer Perform
Mar 31, 2026NeedhamDowngradeBuyHold
Feb 24, 2026Wolfe ResearchInitiated—Outperform
Jan 29, 2026Truist SecuritiesMaintainedBuyBuy
Jan 8, 2026Truist SecuritiesMaintainedBuyBuy
Jan 2, 2026Chardan CapitalMaintainedBuyBuy
Jan 2, 2026Chardan CapitalMaintainedBuyBuy
Dec 10, 2025OppenheimerMaintainedOutperformOutperform
Dec 1, 2025B. Riley SecuritiesMaintainedBuyBuy
Nov 18, 2025GuggenheimMaintainedBuyBuy
Nov 13, 2025Wells FargoMaintainedOverweightOverweight
Nov 7, 2025Wells FargoMaintainedOverweightOverweight
Oct 28, 2025Stephens & Co.Initiated—Overweight
Oct 6, 2025GuggenheimReiteratedBuyBuy
Sep 3, 2025Wells FargoInitiated—Overweight
Aug 12, 2025Chardan CapitalMaintainedBuyBuy
Jul 30, 2025Chardan CapitalMaintainedBuyBuy
Jul 21, 2025Truist SecuritiesInitiated—Buy
May 28, 2025NeedhamInitiated—Buy
May 8, 2025Chardan CapitalInitiated—Buy
Mar 31, 2025Piper SandlerInitiated—Overweight
Mar 26, 2025GuggenheimReiteratedBuyBuy
Feb 10, 2025GuggenheimReiteratedBuyBuy
Jan 7, 2025TD CowenInitiated—Buy
Nov 15, 2024GuggenheimMaintainedBuyBuy
Sep 19, 2024Morgan StanleyUpgradeEqual-WeightOverweight
Sep 19, 2024B. Riley SecuritiesInitiated—Buy